Home Healthcare Pharmaceuticals Meningococcal Vaccine Market

Meningococcal Vaccine Market Size, Share & Trends Analysis Report By Type (Conjugate, Polysaccharide, Subcapsular), By End-User (Children, Adults) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 30, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Meningococcal Vaccine Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Conjugate
    2. Polysaccharide
    3. Subcapsular
  2. Meningococcal Vaccine Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Children
    2. Adults
  3. Regional Meningococcal Vaccine Market
    1. North America
      1. North America Meningococcal Vaccine Market By Type 2022-2034 (USD MILLION/ Units)
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
      2. North America Meningococcal Vaccine Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adults
      3. U.S.
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      4. Canada
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
    2. Europe
      1. Europe Meningococcal Vaccine Market By Type 2022-2034 (USD MILLION/ Units)
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
      2. Europe Meningococcal Vaccine Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adults
      3. U.K.
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      4. Germany
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      5. France
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      6. Spain
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      7. Italy
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      8. Russia
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      9. Nordic
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      10. Benelux
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      11. Rest of Europe
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
    3. APAC
      1. APAC Meningococcal Vaccine Market By Type 2022-2034 (USD MILLION/ Units)
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
      2. APAC Meningococcal Vaccine Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adults
      3. China
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      4. Korea
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      5. Japan
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      6. India
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      7. Australia
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      8. Taiwan
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      9. South East Asia
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      10. Rest of Asia-Pacific
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
    4. Middle East and Africa
      1. Middle East and Africa Meningococcal Vaccine Market By Type 2022-2034 (USD MILLION/ Units)
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
      2. Middle East and Africa Meningococcal Vaccine Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adults
      3. UAE
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      4. Turkey
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      5. Saudi Arabia
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      6. South Africa
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      7. Egypt
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      8. Nigeria
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      9. Rest of MEA
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
    5. LATAM
      1. LATAM Meningococcal Vaccine Market By Type 2022-2034 (USD MILLION/ Units)
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
      2. LATAM Meningococcal Vaccine Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Children
        2. Adults
      3. Brazil
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      4. Mexico
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      5. Argentina
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      6. Chile
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      7. Colombia
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
      8. Rest of LATAM
        1. Conjugate
        2. Polysaccharide
        3. Subcapsular
        4. Children
        5. Adults
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.